Wei, W., Li, X., Feng, Q., Kubo, M., Kullo, I. J., Peissig, P. L., Karlson, E. W., Jarvik, G. P., Lee, M. T. M., Shang, N., Larson, E. A., Edwards, T., Shaffer, C. M., Mosley, J. D., Maeda, S., Horikoshi, M., Ritchie, M., Williams, M. S., Larson, E. B., Crosslin, D. R., Bland, S. T., Pacheco, J. A., Rasmussen-Torvik, L. J., Cronkite, D., Hripcsak, G., Cox, N. J., Wilke, R. A., Stein, C. M., Rotter, J. I., Momozawa, Y., Roden, D. M., Krauss, R. M., & Denny, J. C. (2018). lPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins. Circulation, 138(17), . http://access.bl.uk/ark:/81055/vdc_100086478108.0x000057